|Age:||40 to 89 years old|
|Keywords:||Idiopathic Pulmonary Fibrosis, IPF, pulmonary fibrosis|
|Type:||Drug study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.